🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Open label multicentric randomized phase II trial, using high throughput ge...
Status
Completed
Location
Centre Hospitalier Henri Duffau
Start Date
2014-04-23
Trial ID
NCT02117167
This study will examine the safety, pharmacokinetics, and efficacy of escal...
Status
Terminated
Location
City of Hope National Medical Center ( Site 0004)
Start Date
2019-03-18
Trial ID
NCT03833427
Treatments Being Tested
Background: \- The experimental cancer treatment drug AZD6244 has been sho...
Status
Completed
Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Start Date
2011-01-07
Trial ID
NCT01287130
A study to assess the pharmacokinetics, safety and tolerability of Selumeti...
Status
Completed
Location
Research Site
Start Date
2014-03
Trial ID
NCT02063230
Treatments Being Tested
The primary purpose of the study is to assess the safety, tolerability and ...
Status
Active Not Recruiting
Location
Research Site
Start Date
2007-03-08
Trial ID
NCT00463814
Treatments Being Tested
Background: \- The current standard of care for advanced lung cancer and c...
Status
Completed
Location
National Institutes of Health Clinical Center
Start Date
2011-02-08
Trial ID
NCT01306045
The primary purpose of this study is to compare the efficacy of AZD6244 (AR...
Status
Completed
Location
Research Site
Start Date
2006-07
Trial ID
NCT00338130
Treatments Being Tested
Study to assess the effect of Selumetinib \[AZD6244; ARRY-142886\] \[Hyd-Su...
Status
Completed
Location
Research Site
Start Date
2014-03
Trial ID
NCT02056392
Treatments Being Tested
The goal of this clinical trial is to evaluate the efficacy and safety of t...
Status
Not Yet Recruiting
Location
Beijing Tiantan Hospital, Capital Medical University
Start Date
2026-07-15
Trial ID
NCT07707947
Treatments Being Tested
This is an open-label, non-randomized, multicenter phase Ib/II study, which...
Status
Completed
Location
National Cheng Kung University Hospital
Start Date
2014-09
Trial ID
NCT02025114
Treatments Being Tested